Photosensitizer-conjugated gold nanorods for enzyme-activatable fluorescence imaging and photodynamic therapy

Theranostics

Volumn 2, Issue 2, 2012, Pages 190-197

  Jang, Boseung ^a   Choi, Yongdoo ^a  

^a National Cancer Center   (South Korea)

Author keywords

Enzyme activatable; Gold nanorod; Photodynamic therapy; Quenching; Resonance energy transfer

Indexed keywords

GELATINASE A; GOLD NANOPARTICLE; GOLD NANOROD; NANOROD; OLIGOPEPTIDE; PHOTOSENSITIZING AGENT; PROTEINASE; SINGLET OXYGEN; UNCLASSIFIED DRUG;

ARTICLE; CANCER THERAPY; CHEMICAL STRUCTURE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME SUBSTRATE; FLUORESCENCE; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; HUMAN CELL; IN VITRO STUDY; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; QUANTITATIVE ANALYSIS;

EID: 84864398348     PISSN: None     EISSN: 18387640     Source Type: Journal    
DOI: 10.7150/thno.3478     Document Type: Article

References (24)

1. Hopper C. Photodynamic therapy: a clinical reality in the treatment of cancer. Lancet Oncol. 2000; 1: 212-9.
2. Dolmans DE, Fukumura D, Jain RK. Photodynamic therapy for cancer. Nat Rev Cancer. 2003; 3: 380-7.
3. Choi Y, Weissleder R, Tung CH. Selective antitumor effect of novel protease-mediated photodynamic agent. Cancer Res. 2006; 66: 7225-9.
4. Zheng G, Chen J, Stefflova K, Jarvi M, Li H, Wilson BC. Photodynamic molecular beacon as an activatable photosensitizer based on protease-controlled singlet oxygen quenching and activation. Proc Natl Acad Sci U S A. 2007; 104: 8989-94.
5. Gabriel D, Campo MA, Gurny R, Lange N. Tailoring protease-sensitive photodynamic agents to specific disease-associated enzymes. Bioconjug Chem. 2007; 18: 1070-7.
6. Bae BC, Na K. Self-quenching polysaccharide-based nanogels of pullulan/folate-photosensitizer conjugates for photodynamic therapy. Biomaterials. 2010; 31: 6325-35.
7. Koo H, Lee H, Lee S, Min KH, Kim MS, Lee DS, et al. In vivo tumor diagnosis and photodynamic therapy via tumoral pH-responsive polymeric micelles. Chem Commun (Camb). 2010; 46: 5668-70.
8. Park SY, Baik HJ, Oh YT, Oh KT, Youn YS, Lee ES. A smart polysaccharide/drug conjugate for photodynamic therapy. Angew Chem Int Ed Engl. 2011; 50: 1644-7.
9. Lee SJ, Koo H, Lee D-E, Min S, Lee S, Chen X, et al. Tumor-homing photosensitizer-conjugated glycol chitosan nanoparticles for synchronous photodynamic imaging and therapy based on cellular on/off system. Biomaterials. 2011; 32: 4021-9.
10. McCarthy JR, Weissleder R. Model systems for fluorescence and singlet oxygen quenching by metalloporphyrins. ChemMedChem. 2007; 2: 360-5.
11. Zhu Z, Tang Z, Phillips JA, Yang R, Wang H, Tan W. Regulation of singlet oxygen generation using single-walled carbon nanotubes. J Am Chem Soc. 2008; 130: 10856-7.
12. Jang B, Park JY, Tung CH, Kim IH, Choi Y. Gold nanorod-photosensitizer complex for near-infrared fluorescence imaging and photodynamic/photothermal therapy in vivo. ACS Nano. 2011; 5: 1086-94.
13. Dulkeith E, Ringler M, Klar TA, Feldmann J, Munoz Javier A, Parak WJ. Gold nanoparticles quench fluorescence by phase induced radiative rate suppression. Nano Lett. 2005; 5: 585-9.
14. Jain PK, Lee KS, El-Sayed IH, El-Sayed MA. Calculated absorption and scattering properties of gold nanoparticles of different size, shape, and composition: applications in biological imaging and biomedicine. J Phys Chem B. 2006; 110: 7238-48.
15. Griffin J, Singh AK, Senapati D, Rhodes P, Mitchell K, Robinson B, et al. Size- and distance-dependent nanoparticle surface-energy transfer (NSET) method for selective sensing of hepatitis C virus RNA. Chemistry. 2009; 15: 342-51.
16. Bremer C, Tung CH, Weissleder R. In vivo molecular target assessment of matrix metalloproteinase inhibition. Nat Med. 2001; 7: 743-8.
17. Stearns ME, Wang M. Type IV collagenase (M(r) 72,000) expression in human prostate: benign and malignant tissue. Cancer Res. 1993; 53: 878-83.
18. Davies B, Waxman J, Wasan H, Abel P, Williams G, Krausz T, et al. Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. Cancer Res. 1993; 53: 5365-9.
19. Zucker S, Hymowitz M, Conner C, Zarrabi HM, Hurewitz AN, Matrisian L, et al. Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications. Ann N Y Acad Sci. 1999; 878: 212-27.
20. Fang J, Shing Y, Wiederschain D, Yan L, Butterfield C, Jackson G, et al. Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model. Proc Natl Acad Sci U S A. 2000; 97: 3884-9.
21. Liao H, Hafner JH. Gold Nanorod Bioconjugates. Chemistry of Materials. 2005; 17: 4636-41.
22. Orendorff CJ, Murphy CJ. Quantitation of metal content in the silver-assisted growth of gold nanorods. J Phys Chem B. 2006; 110: 3990-4.
23. AL-OMARI S. Energy transfer of pyropheophorbide a methyl ester in dimethylformamide solutions. Rom J Biophys. 2010; 20: 295-314.
24. Bechet D, Couleaud P, Frochot C, Viriot ML, Guillemin F, Barberi-Heyob M. Nanoparticles as vehicles for delivery of photodynamic therapy agents. Trends Biotechnol. 2008; 26: 612-21.